Prevalence of Sepsis in Pediatric Populations by Barnes, Brittany
Otterbein University 
Digital Commons @ Otterbein 
Nursing Student Class Projects (Formerly MSN) Student Research & Creative Work 
Summer 2015 
Prevalence of Sepsis in Pediatric Populations 
Brittany Barnes 
Otterbein University, brittany.barnes@otterbein.edu 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Bacterial Infections and Mycoses Commons, Medical Pathology Commons, and the 
Nursing Commons 
Recommended Citation 
Barnes, Brittany, "Prevalence of Sepsis in Pediatric Populations" (2015). Nursing Student Class Projects 
(Formerly MSN). 73. 
https://digitalcommons.otterbein.edu/stu_msn/73 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Significance of Pathophysiology 
Alqahtani, M. F., Marsillio, L. E., &  
     Rozenfeld, R. A. (2014). A Review of  
     Biomarkers and Physiomarkers in  
     Pediatric Sepsis. Clinical Pediatric  
     Emergency Medicine, 15(2), 177-184. 
Balamuth, F., Weiss, S. L., Neuman, M. I., 
     Scott, H., Brady, P. W., Paul, R., &  
     Alpern, E. R. (2014). Pediatric Severe  
     Sepsis in U.S. Children's Hospitals*.  
     Pediatric Critical Care Medicine, 15(9),   
     798-805. 
Byrne, L. K. (2014). Nursing  
     management of pediatric sepsis.  
     Clinical Pediatric Emergency Medicine,  
     15(2), 128-130. 
Kortgen, A., Hofmann, G., & Bauer, M.  
     (2006). Sepsis-current aspects of  
     pathophysiology and implications for  
     diagnosis and management. European  
     Journal of Trauma, 32(1), 3-9. 
Steen, C. (2009). Developments in the  
     management of patients with sepsis.  
     Nursing Standard, 23(48), 48-56 
Umbriaco, F., & Andreoni, C. (2013).  
     Pediatric sepsis: a case study.   
     Advanced Emergency Nursing Journal,  
     35(4), 303-313.  
Prevalence of Sepsis in Pediatric Populations 
Brittany Barnes, RN, BSN, CCRN 
Introduction 
Signs and Symptoms 
Additional Sources 
     Those within the pediatric population 
who pose the greatest risk of developing 
sepsis include patients with indwelling 
vascular and urinary catheters, after 
recent surgery, and those that are 
immunocompromised, no matter the 
cause. Patients with sepsis generally 
exhibit characteristic signs and 
symptoms. The hallmark sign of sepsis is 
either hyperthermia or hypothermia 
associated with the onset of a new 
infection. The disease process is also 
associated with the symptoms of 
tachycardia, hyperglycemia without the 
incidence of diabetes, lethargy, warm 
skin, increased cardiac output, chills, and 
muscle weakness. Severe sepsis or septic 
shock is differentiated from sepsis by 
the presence of hypotension, decreased 
cardiac output, and other complications 
including liver failure, acute respiratory 
distress syndrome, encephalopathy, 
renal failure, disseminated intravascular 
coagulopathy, and multiple organ 
dysfunction syndrome (Duran-Bedolla, 
2014).  
      Sepsis is a complex disease 
originating from the infiltration of a 
microorganism into a host’s body and the 
resulting improper inflammatory 
response and dysregulation of 
compensatory mechanisms such as the 
anti-inflammatory response. The 
ramifications of the body’s inappropriate 
response to the microorganism induces 
cellular death thus leading to organ 
dysfunction and even death if severe. 
Despite many medical advances sepsis 
still maintains high morbidity and 
mortality rates especially for those 
children who are most at risk, including 
those that are hospitalized and 
immunosuppressed. According to the 
CDC, patients with sepsis still maintain 
higher risks of complications, receive 
longer treatment, and achieve higher 
healthcare costs (2014).  Early 
recognition and utilization of sepsis 
specific interventions has been proven to 
reduce the mortality rate but little has 
been shown if it affects the morbidity 
rate for patients. Sepsis remains a 
complicated disease course and is 
entirely dependent on each person’s 
inflammatory response and 
compensatory responses with its 
prevalence remaining and mortality 
rates remaining high in the pediatric 
population. 
 Otterbein University, Westerville, Ohio  
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     Though there has been a vast amount of advances with the medical field, sepsis 
is still a difficult disease to treat. It has been proven that early identification and 
disease specific intervention can reduce the morbidity and mortality of sepsis and 
even possibly prevent severe sepsis from becoming septic shock, or sepsis 
associated with hypotension. At the Methodist Medical Center of Illinois a sepsis 
initiative called “Think Sepsis” was created including sepsis specific training of 
those nursing staff that are often the first to encounter patients suffering from 
sepsis. This medical center also utilized a sepsis trigger tool that allowed for early 
recognition and documentation of sepsis. At this hospital prior to the completion of 
the sepsis initiative, in 2009 their mortality rate for patients was 19%.  In 2011, 
two years after the initiative was started, their mortality rate had decreased to 
11% (Hale, 2011). Nurses who are trained in the signs and symptoms of early 
sepsis can alert the medical team of their findings and potentially stop the 
progression of severe sepsis to septic shock. 
 
Implications for Nursing Care 
Underlying Pathophysiology 
     Sepsis and its associated symptoms are caused by a microorganism, and the body’s 
dysregulation of compensatory mechanisms. There are 3 phases associated with 
sepsis after the microorganism has infiltrated the host body:  
• The release of inflammatory mediators  
• The lack of an appropriate anti-inflammatory response  
• The subsequent immunoparalysis due to excessive inflammatory 
mediators present 
     The morbidity and mortality of sepsis is not from the disease process alone 
but is associated with the sequelae of organ dysfunction that sepsis may cause. 
During septic shock there is an inadequate oxygen perfusion to cells. This 
hypoxia causes an increase in reactive oxygen species and reactive nitrogen 
species. Reactive oxygen species can break polypeptide chains and change the 
charge of proteins which is associated with the misfolding or degradation of 
proteins. Reactive nitrogen species yield nitric oxide causing microvascular 
damage and vascular vasodilation which produces hypotension. Excessive 
amounts of nitric oxide can also cause cellular apoptosis which can progress to 
organ dysfunction. After prolonged organ dysfunction, death may occur 
depending on the patient and their specific inflammatory response. Sepsis has 
the capacity to cause fevers, tachycardia, and mild hypotension in some patients 
while other patients suffer the sequelae of irreversible organ damage or death 
(Duran-Bedolla, 2014).  
    Sepsis and more specifically 
septic shock in the pediatric 
population is a diagnosis that is full 
of complexities. There are instances 
where a neutropenic oncology 
patient observes a better outcome 
than a previously healthy patient 
who is suffering from the same 
pathogen related sepsis. Sepsis is 
the 10th leading cause of death 
according to the Center for Disease 
Control and Prevention, and each 
year between 20,000 and 42,000 
children are diagnosed with severe 
sepsis (Riley & Wheeler, 2012).  
Even with significant advances in 
medical treatment, sepsis is still 
associated with high morbidity and 
mortality rates. A retrospective 
study of patient outcomes across 26 
countries found that pediatric 
sepsis mortality was 25%, was 
seemingly unaffected by age, and 
had only mild variations across 
developed countries. Of the 
survivors, 20% suffered from a 
form of moderate functional 
disability (Weiss et al., 2015). 
Despite the amount of clinical trials 
and research associated with 
pediatric sepsis its incidence 
continues to increase by close to 
1.5% annually (Riley & Wheeler, 
2012). 
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     After a microorganism has managed to invade a host, the body enters a 
proinflammatory phase. Gram negative and gram positive organisms cause the 
release of toxic substances into the body including endotoxins, exotoxins, 
lipoteichoic acids, and peptidoglycan. These toxic substances cause the release of 
macrophages, monocytes, platelets, polymorphonuclear leukocytes, and cytokines 
such as tumor necrosis factor α and interleukin 1, 6, 8, and 10. The tumor necrosis 
factor and interleukins cause endothelial cell and leukocyte adhesion, increase 
tissue coagulation factor levels causing coagulation, increase production of nitric 
oxide which results in vascular vasodilation, inhibit anticoagulation by decreasing 
thrombomodulin, and cause the activation of the complement cascade. These 
responses to tumor necrosis factor and interleukins result in inflammation. The 
cytokines present causes endothelial dysfunction which leads to capillary leak and 
eventually impaired perfusion. Because tissue and cell perfusion is inadequate, 
hypoxic cellular necrosis apoptosis occurs. Organ dysfunction and end organ 
failure results from cellular death (Sagy, Al-Qaqaa, & Kim, 2013).  
     Next the body’s negative feedback loop to inflammation causes an anti-
inflammatory response. Anti-inflammatory mediators should inhibit T-lymphocyte 
function, immunoglobulins, tumor necrosis factor α, and inhibit activation of the 
coagulation cascade in a properly functioning inflammatory response. With sepsis, 
there is an increased proinflammatory response to mediators which the body tries 
to compensate with by causing an excessive anti-inflammatory response. 
Eventually the excessive anti-inflammatory response leads to a relative 
immunosuppression and proliferation of inflammation that ultimately may lead to 
multiple organ dysfunction syndrome.  The Center for Disease Control and Prevention recommends using the above 
trigger tool for early diagnosis and treatment of sepsis patients. 
This image demonstrates endothelial damage neutrophil activation, and 
monocytes that activate the complement cascade which leads to the associated 
symptoms of sepsis and multiple organ failure 
